Calm, thoughtful, and steady, she inspires progress through quiet confidence
This phase 3 trial directly compares CagriSema 2.4 mg/2.4 mg against tirzepatide 15 mg in approximately 800 adults with obesity
Omega-3s moisturise the skin and ease dryness, leaving you with a more balanced tone
F., Chen, N., Simmler, C., Lankin, D
Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L